Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial

Table 1 Study groups in the clinical trial

Group	Number of capsules (1 = 250 mg of cinnamon)
Group	Cinnamon	Placebo	Total
Group 1 (250 mg of cinnamon)	1	1	2
Group 2 (500 mg of cinnamon)	2	0	2
Group 3 (placebo)	0	2	2

ISSN: 1745-6215